Boothbay Fund Management’s Otonomy, Inc. OTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-21,048
Closed -$51K 2850
2022
Q1
$51K Hold
21,048
﹤0.01% 2180
2021
Q4
$44K Hold
21,048
﹤0.01% 1780
2021
Q3
$40K Sell
21,048
-3,165
-13% -$5.37K ﹤0.01% 1843
2021
Q2
$54K Buy
+24,213
New +$55.9K ﹤0.01% 1764
2021
Q1
Sell
-64,177
Closed -$415K 1887
2020
Q4
$415K Sell
64,177
-7,308
-10% -$33.2K 0.02% 825
2020
Q3
$290K Sell
71,485
-102,370
-59% -$386K 0.02% 816
2020
Q2
$629K Sell
173,855
-48,869
-22% -$127K 0.04% 522
2020
Q1
$439K Buy
222,724
+34,649
+18% +$107K 0.04% 477
2019
Q4
$720K Hold
188,075
0.06% 392
2019
Q3
$449K Hold
188,075
0.04% 483
2019
Q2
$517K Buy
188,075
+2,072
+1% +$5.52K 0.05% 404
2019
Q1
$489K Buy
+186,003
New +$419K 0.05% 389

Other funds holding OTIC

Boothbay Fund Management's OTIC Position: Q2 2022 in Review

Boothbay Fund Management sold out of Otonomy, Inc. (OTIC) in Q2 2022, closing a stake of 21,048 shares — an estimated $51K sold.

Boothbay Fund Management first reported a position in OTIC in Q1 2019 and held it in 12 quarters. The position peaked at $720K in Q4 2019. 50 funds tracked by Wall St. Rank hold OTIC as of Q2 2022.

  • Boothbay Fund Management reported no remaining Otonomy, Inc. position as of Q2 2022 after selling out during the quarter.
  • Boothbay Fund Management sold 21,048 Otonomy, Inc. shares in Q2 2022, an estimated $51K.
  • Boothbay Fund Management first reported a position in Otonomy, Inc. in Q1 2019 and held it in 12 quarters.
  • Boothbay Fund Management's Otonomy, Inc. position peaked at $720K in Q4 2019.
  • 50 funds tracked by Wall St. Rank held Otonomy, Inc. as of Q2 2022.

Based on Boothbay Fund Management's 13F filing for Q2 2022, filed 15 Aug 2022.